Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aegerion’s Lomitapide Gets Standard Review For Rare Genetic Cholesterol Disease

Related Content

Genzyme/Isis On Track To Submit Cholesterol Drug Mipomersen In 1H 2011

Sep 01 2010

Mipomersen Brings Better-Than-Expected Phase III Results, But Some Questions Linger

May 22 2009

Related Companies

Aegerion Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Pfizer Inc.

Additional Topics

Drug Approval Standards Post Market Regulation & Studies BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window